Found 9 matching trials
IFN Beta-1b and Ribavirin for Covid-19
PHASE2As of 1 July 2020, more than 10 million people been confirmed to have infec...
Location
The University of Hong Kong, Queen Mary Hospital
IFN-beta 1b and Remdesivir for COVID19
PHASE2A 5-day combination of interferon β-1b and remdesivir will expedite the rec...
Location
Queen Mary Hospital
Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
PHASE2To conduct an open-label randomized controlled trial on a short course of i...
Location
The University of Hong Kong, Queen Mary Hospital
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
PHASE2In adults with COVID-19 without criteria for hospitalization or oxygen ther...
Location
Bordeaux university Hospital
Double Therapy With IFN-beta 1b and Hydroxychloroquine
PHASE2The novel coronavirus (SARS-CoV-2), is a single-stranded RNA coronavirus. T...
Location
The University of Hong Kong, Queen Mary Hospital
Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
N/AA Web based real world observational study in Relapsing-Remitting Multiple ...
Location
Multiple Locations
Flupirtine as Oral Treatment in Multiple Sclerosis
PHASE2Flupirtine, a non-opioid analgesic drug, that has been shown to have additi...
Location
NeuroCure Clinical Research Center, Charité Berlin
Atorvastatin in Relapsing-Remitting Multiple Sclerosis
PHASE2A phase II open-label baseline-to-treatment trial was designed to evaluate ...
Location
Multiple Locations
Interferon ß-1b Treatment by Cyclical Administration
PHASE2The therapy with Interferon-ß-1b reduces the inflammatory component of mult...
Location
Azienda Ospedaliera S. Andrea, II Facoltà di Medicina e Chirurgia, Università di Roma "La Sapienza"